Sansure Biotech Inc. (SHA:688289)
China
· Delayed Price · Currency is CNY 18.56
+0.15 (0.81%)
Mar 10, 2026, 2:34 PM CST
Sansure Biotech Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Market Capitalization | 10,571 | 10,858 | 13,001 | 11,187 | 12,747 | 23,600 | Upgrade
|
| Market Cap Growth | -15.51% | -16.48% | 16.22% | -12.24% | -45.99% | -48.22% | Upgrade
|
| Enterprise Value | 7,758 | 8,045 | 8,982 | 6,408 | 7,417 | 18,716 | Upgrade
|
| Last Close Price | 18.41 | 18.91 | 22.10 | 18.55 | 20.05 | 34.89 | Upgrade
|
| PE Ratio | 54.15 | 54.80 | 47.17 | 30.76 | 6.58 | 10.52 | Upgrade
|
| Forward PE | 26.78 | 8.19 | 8.19 | 8.19 | 8.19 | 12.20 | Upgrade
|
| PS Ratio | 6.41 | 6.59 | 8.92 | 11.11 | 1.98 | 5.23 | Upgrade
|
| PB Ratio | 1.46 | 1.50 | 1.77 | 1.51 | 1.70 | 3.70 | Upgrade
|
| P/TBV Ratio | 1.81 | 1.86 | 1.88 | 1.62 | 1.72 | 3.73 | Upgrade
|
| P/FCF Ratio | - | - | - | - | 6.37 | 15.69 | Upgrade
|
| P/OCF Ratio | - | - | 47.37 | 256.93 | 4.98 | 12.57 | Upgrade
|
| EV/Sales Ratio | 4.71 | 4.88 | 6.16 | 6.36 | 1.15 | 4.15 | Upgrade
|
| EV/EBITDA Ratio | 22.61 | 23.45 | 33.53 | 80.30 | 3.27 | 7.28 | Upgrade
|
| EV/EBIT Ratio | 38.32 | 39.74 | 70.58 | - | 3.38 | 7.41 | Upgrade
|
| EV/FCF Ratio | - | - | - | - | 3.71 | 12.44 | Upgrade
|
| Debt / Equity Ratio | 0.15 | 0.15 | 0.06 | 0.01 | 0.00 | 0.00 | Upgrade
|
| Debt / EBITDA Ratio | 3.21 | 3.21 | 1.53 | 0.40 | 0.01 | 0.01 | Upgrade
|
| Debt / FCF Ratio | - | - | - | - | 0.01 | 0.01 | Upgrade
|
| Net Debt / Equity Ratio | -0.40 | -0.40 | -0.59 | -0.64 | -0.75 | -0.73 | Upgrade
|
| Net Debt / EBITDA Ratio | -8.46 | -8.46 | -16.08 | -59.44 | -2.48 | -1.81 | Upgrade
|
| Net Debt / FCF Ratio | - | - | 29.37 | 13.64 | -2.82 | -3.10 | Upgrade
|
| Asset Turnover | - | - | 0.17 | 0.11 | 0.79 | 0.72 | Upgrade
|
| Inventory Turnover | - | - | 0.73 | 0.77 | 8.04 | 3.97 | Upgrade
|
| Quick Ratio | - | - | 7.05 | 5.98 | 4.48 | 8.29 | Upgrade
|
| Current Ratio | - | - | 7.67 | 6.47 | 4.79 | 8.99 | Upgrade
|
| Return on Equity (ROE) | 2.72% | 2.72% | 3.06% | 4.66% | 27.88% | 40.31% | Upgrade
|
| Return on Assets (ROA) | - | - | 0.93% | -0.15% | 16.86% | 25.17% | Upgrade
|
| Return on Invested Capital (ROIC) | 4.69% | 5.50% | 3.86% | -0.78% | 102.20% | 186.47% | Upgrade
|
| Return on Capital Employed (ROCE) | - | - | 1.60% | -0.30% | 28.90% | 39.30% | Upgrade
|
| Earnings Yield | 1.87% | 1.82% | 2.12% | 3.25% | 15.19% | 9.50% | Upgrade
|
| FCF Yield | - | - | -1.13% | -3.11% | 15.69% | 6.37% | Upgrade
|
| Dividend Yield | 2.93% | - | 2.38% | 2.49% | 6.47% | 2.18% | Upgrade
|
| Payout Ratio | - | - | 97.39% | 110.10% | 33.92% | 19.61% | Upgrade
|
| Buyback Yield / Dilution | 0.61% | 0.61% | 0.05% | -0.26% | 0.59% | -6.55% | Upgrade
|
| Total Shareholder Return | 3.54% | 0.61% | 2.42% | 2.23% | 7.07% | -4.37% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.